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416a Monday, February 17, 2014sufficient for resolving the different DNA bases and paving the way for DNA
sequencing in the MHz regime.
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Acetylcholine is a highly important non-electroactive neurotransmitter in the
mammalian central nervous system. Its function is linked to memory and sleep,
and it regulates, in part, mood and action via its connection to dopamine. A fast,
sensitive method to detect the release of acetylcholine at the surface of a single
cell is needed to gather data about the kinetics of exocytosis events in these
systems.
To this end, carbon fiber electrodes have been modified with electrodeposited
gold nanoparticles to increase the effective electrode surface area and provide a
high curvature surface for enzyme attachment. Acetylcholinesterase and
choline oxidase were then deposited onto the gold surfaces to catalyze acetyl-
choline to hydrogen peroxide for electrochemical detection. The functionalized
electrodes have been characterized to determine the KM and Vmax of the en-
zymes as well as the total enzyme coverage and gold nanoparticle surface
area in order to optimize retained enzyme activity. This optimized design has
proven capable of detecting release events from an artificial exocytotic system
on a sub-second time scale.
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Quantitative nucleic acid detection is the future for precision molecular medi-
cine. However, multiple sample preparation steps and thermal heat cycles of
PCR are necessary for nucleic acid (NA) analysis. We developed a single-
step isothermal digital NA amplification microfluidic platform by a technique
termed digital plasma separation. We invented an innovative biophysical mi-
crocliff design that allows the removal of blood cells based on inertia; it can
skim plasma into 224 wells (100nl/well) in one-step (>99% separation effi-
ciency for 6mm particles). By separating the blood cells that obstruct optical
detection, the microcliff design enabled quantitative DNA detection via an
isothermal DNA amplification technique called Recombinase Polymerase
Amplification (RPA) in 30 minutes directly from human blood samples. We
were able to perform endpoint quantitative digital RPA with a dynamic range
of 10~1000 copies/ml via automatic compartmentalization of the samples. The
precise control of fluid flow on chip is accomplished by passive degas-driven
flow actuation, which does not require external tubing or pumps, thus making
the chip portable. A large amount of sample (~100ml of blood samples) can be
processed. We envision this single-step digital blood plasma separation plat-
form will benefit low cost quantitative molecular diagnostics in both developed
and developing countries.
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Type 1 diabetes (T1D) is characterized as a chronic autoimmune disease caused
by a selective inflammatory destruction of the insulin producing beta cells in
the pancreatic islets of Langerhans. Closely associated to T1D are insulin au-
toantibodies (IAAs), representing early markers of the disease. Therefore, their
reliable detection is needed i) to predict the onset of T1D, ii) to implement suc-
cessful regenerative therapies and iii) to prevent loss of the beta cell mass. For
this purpose, we developed a novel optical assay for the detection of IAAs using
single molecule detection. Our quantitative approach specifically detects IAAs
in the low pM range using quantum dots and total internal reflection micro-
scopy (TIRF). This method overcomes the limitations associated with current
clinical diagnostic approaches where IAAs are detected using radiolabelled an-
tigens in a time-consuming, hazardous and expensive manner. Thus, we believe
that in the future our assay could be used as a point of care measurement for
T1D, readily usable in the health care sector combining the prognostic and
diagnostic measurements of autoantibodies in T1D.2102-Pos Board B832
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Electrochemical detection strategies employing nanotechnologies which
include a variety of new materials and fabrication processes offer new oppor-
tunities for highly sensitive detection of cancer biomarkers. This work reports
an electrochemical biosensor based on a graphene (GR) platform, combined
with magnetic beads (MBs) and enzyme-labeled antibody-gold nanoparticle
bioconjugates. MBs coated with capture antibodies (Ab1) were attached to iso-
lated GR sheets by an external magnetic field, to avoid reducing the conductiv-
ity of graphene. Sensitivity was also enhanced by modifying the gold
nanoparticles (AuNPs) with horseradish peroxidase (HRP) and the detection
antibody (Ab2), to form the conjugate Ab2-AuNPs-HRP. Electron transport be-
tween the electrode and analyte target was accelerated by the multi-
nanomaterial, and the limit of detection (LOD) for carcinoembryonic antigen
(CEA) reached 5ng/mL, which meets clinical requirements. The multi-
nanomaterial electrode GR/MBs-Ab1/Antigen/Ab2-AuNPs-HRP can be
used to detect biomolecules
such as CEA. The EC
biosensor is sensitive and
specific, and has potential
in the detection of disease
markers.
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We show experimentally and theoretically that significant currents can be ob-
tained with a biological ion channel, the OmpF porin of Escherichia coli, using
zero-average potentials as driving forces. The channel rectifying properties can
be used to pump potassium ions against an external concentration gradient un-
der asymmetric pH conditions. The results are discussed in terms of the ionic
selectivity and rectification ratio of the channel. The physical concepts
involved may be applied to separation processes with synthetic nanopores
and to bioelectrical phenomena.
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Neurodegenerative diseases share common molecular mechanisms in disease
pathogenesis: protein misfolding and abnormal aggregation. Current detection
methods of protein aggregations require time-consuming and labor-intensive
steps, which delay the process of drug discovery and understanding the mech-
anism of protein aggregation. Here, we present a rapid detection method for
studying protein aggregation and inhibition under a variety of perturbation con-
ditions by dual functions of gold nanoplasmonic particles (GNPs): catalytic
activator and optical reporter. As a proof-of-concept demonstration, we em-
ployed the acidic perturbation permitting rapid cooperative assemblies of
GNPs and amyloid-b (Ab) peptides (implicated in Alzheimer’s disease) via
their surface charge modulation. Because of roles of GNPs as effective nucle-
ation sites for fast-catalyzing protein aggregation and colorimetric optical re-
porters for tracking protein aggregation, we accomplished the fast
aggregation assay in less than 1 min by the naked eyes. Under the given acidic
perturbation condition, we characterized the concentration-dependent colori-
metric responses for aggregation at physiologically relevant Ab concentration
levels without any instrumentation. We also demonstrated the GNP/acidic
condition-based rapid inhibition assay of Ab aggregation by using well-
known binding reagents such as antibody and serum albumin. Consistent results
were also obtained from the tests with superoxide dismutase protein implicated
in Lou Gehrig’s disease. The proposed methodology can be a powerful
